Back to search results

Neuralli Mood for Stress and Sleep

This study is testing a dietary supplement called Neuralli Mood to see if it can help adults who are experiencing stress, occasional sleep problems, low mood, anxiety, or work-related burnout. Neuralli Mood contains two specific probiotic strains, L. plantarum PS128 and L. paracasei PS23. You could join if you are an adult (18 or older) and generally healthy but experiencing these issues. The study will look at changes in your stress levels and sleep quality after taking Neuralli Mood for 90 days. The current status of this study is unclear, and it plans to enroll 100 participants.

Study design
This is a single-arm study, meaning all participants will receive the Neuralli Mood supplement. It is an open-label study, so both you and the researchers will know you are taking the supplement.
What's involved
You would take two capsules of Neuralli Mood once daily for 90 days. You will also complete electronic assessments at the beginning and end of the 90-day period, with check-ins for safety and adherence.
Compensation
Not stated in the trial record.
Follow-up
You will be assessed at the end of the 90-day supplementation period, which is when the primary outcomes are measured.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07717385

Sleep More, Stress Less: 90-Day Trial of Neuralli Mood

Recruiting
NAAges 18+Interventional
Efforia, Inc
~100 participants
Updated 2026-07-21 on ClinicalTrials.gov
What's tested:Neuralli Mood

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Change in Depression Anxiety and Stress Scales-21 Stress Subscale Score
Measured over Baseline before the first dose and end of the 90-day supplementation period
+1 more outcome measured

Conditions

Psychological Stress
Sleep Disturbance
Anxiety Symptoms
Depressive Symptoms
Occupational Burnout

Explore related trials

AnxietyBurnout, ProfessionalDepressionPsychological stressSleep Disorder

Where it's being run

1 sites across 1 states
New York1

Study leadership

  • Matthew Amsden · PRINCIPAL_INVESTIGATOR · Efforia, Inc

Who to contact

Matthew Amsden
[email protected]
+13232844626
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Age 18 years or older and able to provide informed consent.
Generally healthy adult experiencing stress, occasional sleep disruption, low mood, anxiety symptoms, or work-related burnout.
Willing and able to take two capsules of Neuralli Mood daily for 90 days.
Willing and able to complete electronic baseline, follow-up, adherence, and safety assessments.
Has reliable access to the internet and an email-enabled device.

Exclusion

Pregnant or nursing.
Known allergy or hypersensitivity to Neuralli Mood, probiotics, or any product ingredient.
Severe or unstable gastrointestinal disease, including a condition for which probiotic use may be inappropriate.
Immunocompromised status or current immunosuppressive therapy.
Severe or unstable mood disorder, acute psychiatric symptoms, or a current risk of harm to self or others.
A clinically significant sleep disorder for which participation or changes in symptoms should be managed by a healthcare professional.
Cognitive impairment or another condition that prevents informed consent or reliable completion of study procedures.
History of a severe allergic reaction when the investigator determines probiotic use may present an unacceptable risk.
Use of a medication or presence of a medical condition for which a healthcare professional advises against probiotic supplementation.
Any other circumstance that, in the investigator's judgment, makes participation inappropriate or unsafe.

What this trial measures

  • Change in Depression Anxiety and Stress Scales-21 Stress Subscale ScoreBaseline before the first dose and end of the 90-day supplementation period

    Change from baseline in the Stress subscale score of the Depression Anxiety and Stress Scales-21. Higher scores (maximum score of 42) represent greater severity of stress symptoms. (Minimum score of 0).

  • Change in PROMIS Sleep Disturbance ScoreBaseline before the first dose and end of the 90-day supplementation period

    Change from baseline in the PROMIS Sleep Disturbance score. Higher scores (Maximum 40) represent greater sleep disturbance. Lower (Minimum 8) represent lower sleep disturbance.